Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Stock Appreciation Right (right to purchase) 2015 | Options Exercise | $0 | -3.93K | -100% | $0.00* | 0 | Mar 6, 2024 | Common Stock | 3.93K | $90.06 | Direct | F3 |
transaction | RGA | Stock Appreciation Right (right to purchase) 2016 | Options Exercise | $0 | -9.67K | -100% | $0.00* | 0 | Mar 6, 2024 | Common Stock | 9.67K | $93.53 | Direct | F3 |
Id | Content |
---|---|
F1 | Represents (i) 1,934 shares sold to pay the exercise price the purchase of common stock, and (ii) 880 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 1,112 shares. |
F2 | Represents (i) 4,945 shares sold to pay the exercise price the purchase of common stock, and (ii) 2,086 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 2,638 shares. |
F3 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |